382 related articles for article (PubMed ID: 33359813)
1. Amorphous Solid Dispersions of Felodipine and Nifedipine with Soluplus®: Drug-Polymer Miscibility and Intermolecular Interactions.
Sarpal K; Munson EJ
J Pharm Sci; 2021 Apr; 110(4):1457-1469. PubMed ID: 33359813
[TBL] [Abstract][Full Text] [Related]
2. Phase Behavior of Amorphous Solid Dispersions of Felodipine: Homogeneity and Drug-Polymer Interactions.
Sarpal K; Delaney S; Zhang GGZ; Munson EJ
Mol Pharm; 2019 Dec; 16(12):4836-4851. PubMed ID: 31682129
[TBL] [Abstract][Full Text] [Related]
3. Investigation of phase diagrams and physical stability of drug-polymer solid dispersions.
Lu J; Shah S; Jo S; Majumdar S; Gryczke A; Kolter K; Langley N; Repka MA
Pharm Dev Technol; 2015 Jan; 20(1):105-17. PubMed ID: 25113671
[TBL] [Abstract][Full Text] [Related]
4. Construction of drug-polymer thermodynamic phase diagrams using Flory-Huggins interaction theory: identifying the relevance of temperature and drug weight fraction to phase separation within solid dispersions.
Tian Y; Booth J; Meehan E; Jones DS; Li S; Andrews GP
Mol Pharm; 2013 Jan; 10(1):236-48. PubMed ID: 23110477
[TBL] [Abstract][Full Text] [Related]
5. Solid-state characterization of Felodipine-Soluplus amorphous solid dispersions.
Lu J; Cuellar K; Hammer NI; Jo S; Gryczke A; Kolter K; Langley N; Repka MA
Drug Dev Ind Pharm; 2016; 42(3):485-96. PubMed ID: 26530290
[TBL] [Abstract][Full Text] [Related]
6. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
Altamimi MA; Neau SH
Drug Dev Ind Pharm; 2016 Mar; 42(3):446-455. PubMed ID: 26266965
[TBL] [Abstract][Full Text] [Related]
7. An investigation into the role of polymeric carriers on crystal growth within amorphous solid dispersion systems.
Tian Y; Jones DS; Andrews GP
Mol Pharm; 2015 Apr; 12(4):1180-92. PubMed ID: 25692314
[TBL] [Abstract][Full Text] [Related]
8. Use of the Flory-Huggins theory to predict the solubility of nifedipine and sulfamethoxazole in the triblock, graft copolymer Soluplus.
Altamimi MA; Neau SH
Drug Dev Ind Pharm; 2016; 42(3):446-55. PubMed ID: 26289001
[TBL] [Abstract][Full Text] [Related]
9. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility.
Marsac PJ; Shamblin SL; Taylor LS
Pharm Res; 2006 Oct; 23(10):2417-26. PubMed ID: 16933098
[TBL] [Abstract][Full Text] [Related]
10. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
[TBL] [Abstract][Full Text] [Related]
11. Application of Thermodynamic Phase Diagrams and Gibbs Free Energy of Mixing for Screening of Polymers for Their Use in Amorphous Solid Dispersion Formulation of a Non-Glass-Forming Drug.
Mamidi HK; Rohera BD
J Pharm Sci; 2021 Jul; 110(7):2703-2717. PubMed ID: 33609521
[TBL] [Abstract][Full Text] [Related]
12. Bottom-Up and Top-Down Approaches to Explore Sodium Dodecyl Sulfate and Soluplus on the Crystallization Inhibition and Dissolution of Felodipine Extrudates.
Chen J; Chen Y; Huang W; Wang H; Du Y; Xiong S
J Pharm Sci; 2018 Sep; 107(9):2366-2376. PubMed ID: 29738699
[TBL] [Abstract][Full Text] [Related]
13. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
Tian Y; Caron V; Jones DS; Healy AM; Andrews GP
J Pharm Pharmacol; 2014 Feb; 66(2):256-74. PubMed ID: 24192445
[TBL] [Abstract][Full Text] [Related]
14. Theoretical and experimental investigation of drug-polymer interaction and miscibility and its impact on drug supersaturation in aqueous medium.
Baghel S; Cathcart H; O'Reilly NJ
Eur J Pharm Biopharm; 2016 Oct; 107():16-31. PubMed ID: 27378287
[TBL] [Abstract][Full Text] [Related]
15. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
[TBL] [Abstract][Full Text] [Related]
16. Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).
Marsac PJ; Rumondor AC; Nivens DE; Kestur US; Stanciu L; Taylor LS
J Pharm Sci; 2010 Jan; 99(1):169-85. PubMed ID: 19492305
[TBL] [Abstract][Full Text] [Related]
17. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
18. Quantifying Molecular Mixing and Heterogeneity in Pharmaceutical Dispersions at Sub-100 nm Resolution by Spin Diffusion NMR.
Duan P; Lamm MS; Yang F; Xu W; Skomski D; Su Y; Schmidt-Rohr K
Mol Pharm; 2020 Sep; 17(9):3567-3580. PubMed ID: 32787281
[TBL] [Abstract][Full Text] [Related]
19. Investigation into Intermolecular Interactions and Phase Behavior of Binary and Ternary Amorphous Solid Dispersions of Ketoconazole.
Sarpal K; Tower CW; Munson EJ
Mol Pharm; 2020 Mar; 17(3):787-801. PubMed ID: 31860316
[TBL] [Abstract][Full Text] [Related]
20. A New Method of Constructing a Drug-Polymer Temperature-Composition Phase Diagram Using Hot-Melt Extrusion.
Tian Y; Jones DS; Donnelly C; Brannigan T; Li S; Andrews GP
Mol Pharm; 2018 Apr; 15(4):1379-1391. PubMed ID: 29205040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
